Tuesday, January 31, 2017

Pharma Reviews: Trump calls for drug price-cuts, make in US & ease FDA approvals

Trump, who met the CEOs of major US pharmaceutical companies in a ... And that's a bad news for Indian companies at time when the drug makers ...
Read more: Trump calls for drug price-cuts, make in US & ease FDA approvals

Pharma Reviews: Indian Pharma not too worried over Trump talk

New Delhi: Indian drug makers, who earn almost 50% of their revenues from the American market, are keeping their fingers crossed after US ...
Read more: Indian Pharma not too worried over Trump talk

Pharma Reviews: Indian pharma firms not worried over Trump's drug talk

Though Indian pharmaceutical industry, see Trump's bashing of American Big Pharma industry as an opportunity, it is also cautious due to possibility ...
Read more: Indian pharma firms not worried over Trump's drug talk

Pharma Reviews: Trump's policy can affect India's pharmaceutical companies

Trump asked big pharmaceutical companies to change their pricing policies. He said, "We have to get lower prices, we have to get even better ...
Read more: Trump's policy can affect India's pharmaceutical companies

Pharma Reviews: Buy American: Trump's call to pharma firms to move back to US

​Washington: Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald ...
Read more: Buy American: Trump's call to pharma firms to move back to US

Pharma Reviews: Trump's call to pharma firms to move back to US could hit Indian exporters

WASHINGTON: Foreshadowing "Buy American" moves that could affect the largest market for Indian pharmaceutical companies, US President Donald ...
Read more: Trump's call to pharma firms to move back to US could hit Indian exporters

Pharma Reviews: Indian pharma industry fears tougher US stance on IP

The Indian pharma industry fears a tougher US government stance on intellectual property rules after US President Donald Trump asserted that ...
Read more: Indian pharma industry fears tougher US stance on IP

Pharma Reviews: Pharmaceutical stocks decline on Trump remarks

Analysts said the Indian generic pharma industry has been addressing the need for affordable pharmaceuticals of the US patients and enabled the US ...
Read more: Pharmaceutical stocks decline on Trump remarks

Pharma Reviews: After IT, Trump targets pharma; says will name US FDA chief soon

In what could be a blow to the Indian pharma industry, US President Donald Trump today said that other countries have been taking advantage of the ...
Read more: After IT, Trump targets pharma; says will name US FDA chief soon

Monday, January 30, 2017

Pharma Reviews: Union govt to come out with a scheme to support new pharma and medical device parks

This sector has been gaining significant attention and this event India Pharma and Medical Devices 2017 is expected to garner investments to spur ...
Read more: Union govt to come out with a scheme to support new pharma and medical device parks

US FDA News: Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.: Class I Recall - Sheath Separation, Kinking, or Tip Damage

The affected product may cause serious adverse health consequences such as internal tears and perforation to arteries or veins, excessive bleeding, and death.
Read more: Halo One Thin-Walled Guiding Sheath by Bard Peripheral Vascular Inc.: Class I Recall - Sheath Separation, Kinking, or Tip Damage

Pharma Reviews: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...

To another query on US President Trump's policy impact on India, pharma, Kumar said that there ... I also don't think, there will not be any problem for the Indian pharmaceutical, biotech and information technology sector,” he said.
Read more: Cardiac stent notification by mid-Feb, mandatory UCPMP on the cards, US President Trump's ...

Pharma Reviews: India's IT, Auto, Pharma sectors may face brunt of Trump's border tax

Analysts expects that such would not harm India's economy as it is ... “We expect another muted quarter for the pharma sector led by weakness in US ...
Read more: India's IT, Auto, Pharma sectors may face brunt of Trump's border tax

Pharma Reviews: Biocon aims for the highest quality at the lowest cost: Kiran Mazumdar Shaw

While the rest of the Indian pharma industry followed business models led by small molecules, you decided to focus on technology intensive large ...
Read more: Biocon aims for the highest quality at the lowest cost: Kiran Mazumdar Shaw

Sunday, January 29, 2017

Pharma Reviews: Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar

Union Minister for Chemicals and Fertilizers HN Ananth Kumar BENGALURU: Indian IT, Biotech and pharma industries will not be impacted due to ...
Read more: Donald Trump's policy not to hit Indian IT, pharma firms: Ananth Kumar

Pharma Reviews: We can fix unavailability of medicines: Pradyumn Singh

India is a prescription-led market and distribution in the Indian pharmaceutical sector is very fragmented. There are close to 10 lakh retail shops and ...
Read more: We can fix unavailability of medicines: Pradyumn Singh

Pharma Reviews: IDMA urges Centre to offer capital-linked budget incentives for pharma biz

Ahmedabad: With the Union budget set to be presented next week, Indian Drug Manufacturers Association (IDMA) has urged the Centre to make a ...
Read more: IDMA urges Centre to offer capital-linked budget incentives for pharma biz

Pharma Reviews: Trump's Policy Not to Hit Indian IT, Pharma Firms: Union Minister

Bengaluru: Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the US is expected to continue "the ...
Read more: Trump's Policy Not to Hit Indian IT, Pharma Firms: Union Minister

Pharma Reviews: HC allows Indian firm to export drug in which Bayer has patent

NEW DELHI: In a setback to German pharma major 'Bayer', Delhi High Court has suspended its order restraining an Indian drug company from ...
Read more: HC allows Indian firm to export drug in which Bayer has patent

Saturday, January 28, 2017

Pharma Reviews: 'Notification on stent pricing in 15 days'

The Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers, along with Federation of Indian Chambers of Commerce and Industry will ...
Read more: 'Notification on stent pricing in 15 days'

Pharma Reviews: Trump's policy not to hit Indian IT, pharma firms: Union Minister

Indian IT, Biotech and pharma industries will not be impacted due to Donald Trump's policies as the United States is expected to continue “the ...
Read more: Trump's policy not to hit Indian IT, pharma firms: Union Minister

Pharma Reviews: India Pharma for responsible Healthcare

The Department of Pharmaceuticals (DoP), Ministry of Chemicals and Fertilizers, along with Federation of Indian Chambers of Commerce & Industry ...
Read more: India Pharma for responsible Healthcare

Friday, January 27, 2017

US FDA News: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna

Homeopathic teething products containing belladonna pose an unnecessary risk to infants and children. Posted 01/27/2017
Read more: Certain Homeopathic Teething Products: FDA Warning- Confirmed Elevated Levels of Belladonna

US FDA News: NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents by bioMerieux: Recall - Potential Inaccurate Test Results

Risk of false negative results, invalid results, or under-quantification for clinical laboratory tests. This error may result in inappropriate treatment or delay in treatment.
Read more: NucliSENS easyMAG Magnetic Silica and NucliSENS Magnetic Extraction Reagents by bioMerieux: Recall - Potential Inaccurate Test Results

US FDA News: FDA confirms elevated levels of belladonna in certain homeopathic teething products

The U.S. Food and Drug Administration announced today that its laboratory analysis found inconsistent amounts of belladonna, a toxic substance, in certain homeopathic teething tablets, sometimes far exceeding the amount claimed on the label. The agency is warning consumers that homeopathic teething tablets containing belladonna pose an unnecessary risk to infants and children and urges consumers not to use these products.
Read more: FDA confirms elevated levels of belladonna in certain homeopathic teething products

Pharma Reviews: Pharma has six pain points; Budget 2017 should address them to boost growth

Phasing out of weighted deductions: According to figures, the Indian pharmaceutical sector has the potential to grow exponentially to the size of $300 ...
Read more: Pharma has six pain points; Budget 2017 should address them to boost growth

Pharma Reviews: 'Donald Trump's push for lower drug prices to benefit Indian pharma'

NEW DELHI: Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug ...
Read more: 'Donald Trump's push for lower drug prices to benefit Indian pharma'

Pharma Reviews: Pharma industry wants budget to offer more clarity in terms of...

The industry players want the government to provide a road map towards ... The Indian Drug Manufacturers Association (IDMA), a body comprising ...
Read more: Pharma industry wants budget to offer more clarity in terms of...

Thursday, January 26, 2017

Pharma Reviews: Pharma industry hopes for faster licences

Hyderabad: The Indian pharma industry is pegged around Rs 2 lakh crore and of this the domestic industry is pegged at Rs 1 lakh crore and exports ...
Read more: Pharma industry hopes for faster licences

Pharma Reviews: IPA to organise Technical Conference in Ahmedabad on Jan-28 to improve practice & reporting of ...

In order to help participants improve their practice and reporting of quality metrics to US FDA, the Indian Pharmaceutical Association (IPA) Industrial ...
Read more: IPA to organise Technical Conference in Ahmedabad on Jan-28 to improve practice & reporting of ...

Pharma Reviews: IDMA urges central govt to eliminate bottlenecks in API sector, incentivise exports

Against the backdrop of issues the Indian API industry has been facing and ... to present good commercial opportunities for Indian pharma industry.
Read more: IDMA urges central govt to eliminate bottlenecks in API sector, incentivise exports

Pharma Reviews: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

New Delhi, Jan 25 : The healthcare sector catering to the unmet health ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

Wednesday, January 25, 2017

Pharma Reviews: 'Trump's push for lower drug prices to benefit Indian pharma sector'

Indian pharmaceutical sector is likely to gain, rather than being impacted, as the new US President Donald Trump aims to reduce drug prices since the ...
Read more: 'Trump's push for lower drug prices to benefit Indian pharma sector'

US FDA News: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial

Injected particulate may result in local swelling, irritation of blood vessels or tissue, blockage of blood vessels and/or low-level allergic response to the particulate.
Read more: Vancomycin Hydrochloride for Injection, USP by Hospira: Recall - Particulate Matter in Vial

Pharma Reviews: Healthcare Budget 2017: Government should raise tax exemption on preventive health check-up ...

New Delhi, January 25: The healthcare sector must be kept out of the ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: Healthcare Budget 2017: Government should raise tax exemption on preventive health check-up ...

Pharma Reviews: Indian pharma likely to report tepid earnings growth for Q3 FY17

The Indian pharmaceutical sector has seen a significant share of market value erode over the last couple of years owing to multiple challenges, most ...
Read more: Indian pharma likely to report tepid earnings growth for Q3 FY17

Pharma Reviews: Keep healthcare out of GST purview: Assocham

New Delhi, Jan 25 (PTI) Healthcare sector should be kept outside the ... The Indian pharma industry, with an estimated turnover of USD 36.7 billion in ...
Read more: Keep healthcare out of GST purview: Assocham

Pharma Reviews: Pharma industry seeks more tax clarity & incentives for R&D purposes

With a view to introduce the balance in the rate of excise duties, Indian Drug Manufacturers Association (IDMA) said that all excisable goods used for ...
Read more: Pharma industry seeks more tax clarity & incentives for R&D purposes

Pharma Reviews: Ethical minefield: Pharma industry's gifts to doctors can be tax deductable, rules tribunal

More relevantly, the Medical Council of India regulations pertain to doctors and not to pharmaceutical companies and allied health sector industries.
Read more: Ethical minefield: Pharma industry's gifts to doctors can be tax deductable, rules tribunal

Pharma Reviews: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

So, there is a strong case for the sector to be spared the GST," said ... The Indian pharma industry, with an estimated turnover at USD 36.7 billion in ...
Read more: GST on healthcare will make medicare unaffordable, says ASSOCHAM-TechSci study

Tuesday, January 24, 2017

Pharma Reviews: Budget 2017: Weighted deductions for incurring pharma R&D should continue

The pharmaceutical sector has been one of the key sectors in the shaping up of the Indian economy and it will continue playing a major role in its ...
Read more: Budget 2017: Weighted deductions for incurring pharma R&D should continue

Pharma Reviews: Why India's generic-drug industry has a long way to go to gain US FDA's trust

India supplies 40% of the generic medications consumed in the US, where copycats account for more than 8 in 10 prescriptions. Photo: Bloomberg.
Read more: Why India's generic-drug industry has a long way to go to gain US FDA's trust

Monday, January 23, 2017

Pharma Reviews: Pharma industry wants Budget to offer tax clarity

The Indian Drug Manufacturers Association (IDMA), a body comprising mostly home-grown pharma firms, said all excisable goods used for R&D ...
Read more: Pharma industry wants Budget to offer tax clarity

Pharma Reviews: Japanese lender key financier of pharma M&As

Over the past two-odd years, MUFG has led almost all major outbound merger & acquisition (M&A) financing for Indian pharma companies.
Read more: Japanese lender key financier of pharma M&As

Pharma Reviews: Union Budget 2017: An opportunity to drive innovation and rapid growth in the pharma sector

Budget 2017: The Indian pharmaceutical industry is on the threshold of becoming a major global market by 2020 with revenues close to Rs 1,652 ...
Read more: Union Budget 2017: An opportunity to drive innovation and rapid growth in the pharma sector

Pharma Reviews: Need for promotion of API industry and SMEs to boost pharma industry: IDMA

These were some of the thoughts deliberated as part of the 55th Indian Drug Manufacturers Association (IDMA) annual celebration under the theme ...
Read more: Need for promotion of API industry and SMEs to boost pharma industry: IDMA

Pharma Reviews: Trump's 'America First' policy to maul Indian IT, pharma sectors: Nasscom

The new US administration under President Donald Trump has vowed to follow an isolationist trade policy that is both against global trade norms set ...
Read more: Trump's 'America First' policy to maul Indian IT, pharma sectors: Nasscom

Pharma Reviews: Trump intervention in pharma may affect Indian suppliers: PwC

Shetty said talk of a border tax on imports could lead to a higher cost for Indian pharma companies in terms of exports. He added that even though ...
Read more: Trump intervention in pharma may affect Indian suppliers: PwC

Sunday, January 22, 2017

Pharma Reviews: Over Rs 2500 crore saved in pharma sector post control of ceiling price of 853 formulations

The turnover of the Indian pharmaceutical industry was estimated at Rs 2,04,627.1 crore in FY 2015-16. The Indian pharmaceutical industry has ...
Read more: Over Rs 2500 crore saved in pharma sector post control of ceiling price of 853 formulations

Pharma Reviews: Illegal pharma drugs business hitting Indian markets

This unregulated trade has taken a firm root in India as a supplier and had ... In 2016, more than 500 kg of tablets (pharmaceutical drugs) have been ...
Read more: Illegal pharma drugs business hitting Indian markets

Pharma Reviews: Indian pharma pads up to fight Republican border tax

... for Indian pharmaceutical companies. Republican senators propose to slap a BAT as a tax reform. Under the proposal, US companies would not be ...
Read more: Indian pharma pads up to fight Republican border tax

Saturday, January 21, 2017

Pharma Reviews: IT, pharma in search of Trump card

New Delhi, Jan. 21: Indian pharmaceutical majors and technology giants are in a "wait-and-watch" mode over newly-elected US President Donald ...
Read more: IT, pharma in search of Trump card

Pharma Reviews: Indian pharma firms bat to fight Republican BAT

Under the proposal, US companies would not be taxed for profits from ... Indian generic drug makers said this would hurt their profitability — but also .
Read more: Indian pharma firms bat to fight Republican BAT

Pharma Reviews: Viewing the Indian pharma sector through the biosimilar lens

The Indian pharmaceutical market which would rank amongst the top five in terms of volume is also the largest provider of generic drugs globally.
Read more: Viewing the Indian pharma sector through the biosimilar lens

Friday, January 20, 2017

Pharma Reviews: US border tax: Indian pharma cos may be hit

Mumbai: Domestic pharmaceutical companies may be impacted and could see a rough road ahead in the US, if it decides to implement the proposed ...
Read more: US border tax: Indian pharma cos may be hit

Pharma Reviews: Despite Note Ban, India One Of The Best Emerging Market Growth Stories: Arvind Sanger

Similarly on the pharmaceutical industry, trying to talk down drug prices is a negative but one of the ways you get lower prices is to encourage more ...
Read more: Despite Note Ban, India One Of The Best Emerging Market Growth Stories: Arvind Sanger

Thursday, January 19, 2017

US FDA News: FDA approves Trulance for Chronic Idiopathic Constipation

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.
Read more: FDA approves Trulance for Chronic Idiopathic Constipation

Pharma Reviews: View: Govt should reduce over dependence on Chinese imports of pharma raw materials

Research & development is the backbones of the Indian pharma industry and therefore there is a need to provide an impetus and incentivise R&D ...
Read more: View: Govt should reduce over dependence on Chinese imports of pharma raw materials

US FDA News: Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch

Today the U.S. Food and Drug Administration is establishing the Oncology Center of Excellence (OCE) and appointing Dr. Richard Pazdur as its director. This will make oncology the first disease area to have a coordinated clinical review of drugs, biologics and devices across the agency’s three medical product centers.
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch

Wednesday, January 18, 2017

Pharma Reviews: Gujarat govt signs 249 MoUs with pharma cos attracting investments worth

... Gujarat government has signed MoUs worth Rs. 15,000 crore with both Indian and international companies in the pharma sector during the recently ...
Read more: Gujarat govt signs 249 MoUs with pharma cos attracting investments worth

Pharma Reviews: Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at ...

Indeed the employees continue to work as a one family & one team making Microlabs as India's most respected pharma company with a formidable ...
Read more: Dilip Surana led Microlabs Limited Wins peoples heart, voted as Best Company to work for at ...

Pharma Reviews: Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16

NEW DELHI: Indian pharmaceutical industry grew by 29 per cent to Rs 2,04,627 crore in 2015-16 from Rs 1,77,734 crore in 2014-15, while it attracted ...
Read more: Pharma industry grows 29% to Rs 2.04 lakh crore in 2015-16

Pharma Reviews: IT, pharma companies dominate business travel spending in India in 2015

Information technology and pharmaceutical companies accounted for about 60 per cent of business travel spend in India in 2015 up from about 52 per ...
Read more: IT, pharma companies dominate business travel spending in India in 2015

US FDA News: Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications

We recognize that there is a high level of interest regarding FDA’s views on communications about medical products. We are committed to an ongoing dialogue with industry and other stakeholders, and, when needed, providing guidance to clarify the agency’s thinking on these issues. Today, the FDA released two separate draft guidances that will each help provide clarity for medical product companies, as well as other interested parties, on FDA’s current thinking and recommendations for a few different types of communications about medical products.
Read more: Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications

US FDA News: FDA and EPA issue final fish consumption advice

Today, the U.S. Food and Drug Administration and the U.S. Environmental Protection Agency issued final advice regarding fish consumption. This advice is geared toward helping women who are pregnant or may become pregnant – as well as breastfeeding mothers and parents of young children – make informed choices when it comes to fish that are healthy and safe to eat. (This advice refers to fish and shellfish collectively as “fish.”)
Read more: FDA and EPA issue final fish consumption advice

Pharma Reviews: Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

On January 10th, in a 100 word press release, Japanese pharma major Daiichi Sankyo announced that the company had decided to "to close its ...
Read more: Daiichi Sankyo stumps industry with move to pull the plug on Indian Research and development arm

Pharma Reviews: Meet the top 3 among 84 billionaires who own over half of India's wealth

The three businessmen are among the 84 richest Indian billionaires, ... Sun Pharmaceutical became India's largest and world's fifth largest drug firm ...
Read more: Meet the top 3 among 84 billionaires who own over half of India's wealth

Pharma Reviews: Expect realty sector to rebound in 3-6 months: Morgan Stanley

On the pharmaceutical industry, Baisiwala said that he is constructive on the sector as he expects Indian companies to continue to win market share in ...
Read more: Expect realty sector to rebound in 3-6 months: Morgan Stanley

Tuesday, January 17, 2017

Pharma Reviews: Changes in US put Indian pharma's R&D to test

Indian pharmaceutical companies were dogged by concerns over quality issues, poor regulatory compliance and price fixing in 2016. But even as they ...
Read more: Changes in US put Indian pharma's R&D to test

Pharma Reviews: Indian American on Trump probables list for USFDA chief

The choice is interesting given the bitter sweet relationship that the pharmaceutical industry in the US and India have with the administration.
Read more: Indian American on Trump probables list for USFDA chief

US FDA News: ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE - Follow Pentax Validated Reprocessing Instructions

Updated recommendations to help prevent the spread of infection associated with the use of these devices.
Read more: ED-3490TK Video Duodenoscope by Pentax: FDA Safety Communication - UPDATE - Follow Pentax Validated Reprocessing Instructions

Pharma Reviews: Pharma sector expects a sweet pill from budget 2017

The Indian pharma industry is a very dynamic sector and has witnessed tremendous growth as well as challenges over the last few years.
Read more: Pharma sector expects a sweet pill from budget 2017

Monday, January 16, 2017

Pharma Reviews: Pharmaceutical - Results Preview - Mixed Performance in the US Biz; Domestic Biz to See ...

We expect 3QFY17E will be a mixed quarter for the Indian pharmaceutical companies with some of them are expected to deliver healthy sales growth ...
Read more: Pharmaceutical - Results Preview - Mixed Performance in the US Biz; Domestic Biz to See ...

Pharma Reviews: Indian-American Balaji S Srinivasan under consideration to lead Federal Drug Administration

Indian-American Balaji S Srinivasan, a successful Silicon Valley-based ... (FDA), the all-important federal agency for drug and pharma industry.
Read more: Indian-American Balaji S Srinivasan under consideration to lead Federal Drug Administration

Sunday, January 15, 2017

Pharma Reviews: GlaxoSmithKline Pharmaceuticals: Recovery ahead

With a nearly 4 per cent share, the company is among the major players in the India pharma market — seven of the company's brands, including ...
Read more: GlaxoSmithKline Pharmaceuticals: Recovery ahead

Pharma Reviews: India Markets Weekahead - Be cautious of a big rally before budget

He attacked the pharmaceutical industry for high drug prices and for manufacturing overseas, indicating a major shift in focus. He said he would repeal ...
Read more: India Markets Weekahead - Be cautious of a big rally before budget

Saturday, January 14, 2017

US FDA News: Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery

Device has shut down unexpectedly during patient treatment, which may expose patients to the risk of serious harm or death. Posted 01/14/2017
Read more: Lifepak 1000 Defibrillators by Physio-Control: Voluntary Field Action - Immediately Remove and Reinstall Battery

Pharma Reviews: Q3 results: Five trends to watch out from Indian drugmakers

As Indian drug makers brace up to report their third quarter earnings in the days ... and Aurobindo are the companies to watch out for with half of their ...
Read more: Q3 results: Five trends to watch out from Indian drugmakers

Friday, January 13, 2017

Pharma Reviews: Donald Trump to take office on January 20; 5 factors to watch for Indian markets

Here's is Trump presidency's likely impact on Indian industries: ... We feel IT and Pharma would be affected adversely due to his protectionist policies.
Read more: Donald Trump to take office on January 20; 5 factors to watch for Indian markets

Pharma Reviews: Pricing pressure to continue in US for Indian generics

Kiran Mazumdar Shaw, CMD, Biocon told TOI: “The Indian generic pharma industry has been addressing the need for affordable pharmaceuticals of ...
Read more: Pricing pressure to continue in US for Indian generics

US FDA News: Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use

Fuji removing legacy 250/450 duodenoscope models from clinical use, replacing with with the ED-530XT model.
Read more: Duodenoscopes by Fujifilm Medical Systems: Safety Communication - Certain Older Models Removed From Clinical Use

Pharma Reviews: Enter characters of the above image

Pharma major, Lupin, has launched Morphine Sulfate ER Tablets of 15 mg, 30 mg, 60 mg, ... It is the fourth largest pharmaceutical company in India.
Read more: Enter characters of the above image

Pharma Reviews: Stock to watch out for today: Sun Pharma

Pharma sector could well be the sector to watch out for in 2017. Sun Pharma's performance will be keenly watched as it is one of the largest Indian ...
Read more: Stock to watch out for today: Sun Pharma

Thursday, January 12, 2017

Pharma Reviews: Vibrant Gujarat Summit: Life sciences key to UK-India links, says British high commissioner to India

“In Britain, there are 5,500 companies in the life sciences sector generating 60 billion pounds each year. Gujarat's role in the Indian pharma industry is ...
Read more: Vibrant Gujarat Summit: Life sciences key to UK-India links, says British high commissioner to India

Pharma Reviews: Shot in arm for pharma, medical devices

Ahmedabad: It was raining MoUs for the pharmaceutical and medical ... Saudi Arabia, which had almost no presence in the Indian pharma industry.
Read more: Shot in arm for pharma, medical devices

Pharma Reviews: Indian generic drug players unlikely to be affected by Trump attacks

The Indian pharma industry, which account for nearly 40 per cent of the generic drugs in the US, is unlikely to come under pressure after US ...
Read more: Indian generic drug players unlikely to be affected by Trump attacks

Pharma Reviews: Donald Trump's words spook Indian pharma stocks

MUMBAI: United States president-elect Donald Trump's bashing of the pharmaceuticals industry has pushed shares of Indian drug makers down, as a ...
Read more: Donald Trump's words spook Indian pharma stocks

Pharma Reviews: Pricing pressure to continue in US for Indian generics

MUMBAI: Indian companies will need to buckle up to compete in a fiercely-competitive, but most lucrative market in the world, US, in the wake of a ...
Read more: Pricing pressure to continue in US for Indian generics

Pharma Reviews: Drug firms cautious as Trump raises pricing, off-shoring bogey

But the lobby-ridden drug industry was shaken out of its seeming ... The US is a magnet for Indian drug companies, being the largest market for ...
Read more: Drug firms cautious as Trump raises pricing, off-shoring bogey

Pharma Reviews: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts

On an average, Indian companies are witnessing 8-9% price erosion in generics in the US, which is expected to continue in the next few years.
Read more: Trump's attack on pharma industry won't harm Indian generic drug makers: analysts

Pharma Reviews: Indian drug companies see no threat from Trump's policies

The proposed changes in the US healthcare policies will have minimal impact on Indian companies, drug makers and sector experts said on Thursday ...
Read more: Indian drug companies see no threat from Trump's policies

Pharma Reviews: Indian pharmaceutical sector may take a hit under Trump regime

The US is the largest market for Indian drug makers. In 2015, India exported $6 billion worth of drugs to the US and could feel the impact of the Trump ...
Read more: Indian pharmaceutical sector may take a hit under Trump regime

Pharma Reviews: DoP exempts pharmaceutical companies from lowering drug prices based on WPI

The Indian Pharmaceutical Alliance argued, "The DPCO 2013 mandates reduction of prices only with reference to the Ceiling Price and not the MRPs.
Read more: DoP exempts pharmaceutical companies from lowering drug prices based on WPI

Pharma Reviews: Muted topline Q3 growth in pharma note ban impact marginal

The pharmaceutical sector is expected to report a muted revenue growth of ... "We expect Indian pharma to report revenue growth of 12 per cent and ...
Read more: Muted topline Q3 growth in pharma note ban impact marginal

US FDA News: PNC-27 Products: FDA Warning – Do Not Use For Treatment or Cure for Cancer

Consumers who use a contaminated product are at risk for serious, potentially life-threatening infections.
Read more: PNC-27 Products: FDA Warning – Do Not Use For Treatment or Cure for Cancer

Pharma Reviews: Nifty gains for 3rd day; Trump views drag pharma, Infosys soars

Nifty gains for 3rd day; Trump views drag pharma, Infosys soars ... The market has ended on a strong note fuelled by big gains in IT and power stocks. ..... were down as major Indian pharma companies earn around 15-50 percent ...
Read more: Nifty gains for 3rd day; Trump views drag pharma, Infosys soars

Pharma Reviews: US to dismantle Obamacare Health Insurance scheme, Indian pharma must focus on labour cost ...

However, to remain competitive and allow the market forces to overcome President Trump's initiative, Indian pharmaceutical industry will have to ...
Read more: US to dismantle Obamacare Health Insurance scheme, Indian pharma must focus on labour cost ...

Pharma Reviews: COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma story

COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma ... In automobiles, proximity to the market is not as important as are cost and ...
Read more: COMMENT: Why Trump's rants won't make a dent in Indian IT & pharma story

Pharma Reviews: Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8400

Pharmaceutical shares' extended losses continued to limit the gains in Indian markets, even as IT stocks tried to pull up the benchmark indices, as the ...
Read more: Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8400

Pharma Reviews: 'Trump's pharma card to have disturbing impact on Indian cos'

In a first press meet conducted by President-elect Trump, pharmaceutical companies were targeted. Trump said that pharma companies were "getting ...
Read more: 'Trump's pharma card to have disturbing impact on Indian cos'

Pharma Reviews: Pharmaceutical Stocks Fall As Trump's Comments Rekindle Pricing Worries

Indian drug makers fell in early Thursday trades after U.S. President-elect Donald Trump said pharmaceutical companies were "getting away with ...
Read more: Pharmaceutical Stocks Fall As Trump's Comments Rekindle Pricing Worries

Pharma Reviews: Pharma Q3: FDA inspection, US pricing market key

Pharmaceutical companies in India are expected to post muted results for the third quarter ended December 31, 2016. Piyush Nahar and Anurag ...
Read more: Pharma Q3: FDA inspection, US pricing market key

Pharma Reviews: No scope of US intervention in Indian pharma cos: Wockhardt

Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for ...
Read more: No scope of US intervention in Indian pharma cos: Wockhardt

Pharma Reviews: Biocon sustains Trump tamper; up more than 2%

Majority of the Indian Pharma companies which have operations in the US markets are trading down, however, Biocon was the only stock in the ...
Read more: Biocon sustains Trump tamper; up more than 2%

Wednesday, January 11, 2017

Pharma Reviews: Indian exports to be hit? Prioritising job creation, Trump targets pharmas

"Our drug industry has been disastrous. They're leaving left and right. They supply our drugs, but they don't make them here, to a large extent." India ...
Read more: Indian exports to be hit? Prioritising job creation, Trump targets pharmas

Pharma Reviews: Pharma falls on Trump's comments, analysts say impact unlikely

Major Indian pharma companies earn around 15-50 percent revenue from the US ... Shares of pharma companies were under pressure following US ...
Read more: Pharma falls on Trump's comments, analysts say impact unlikely

Pharma Reviews: Pharma stocks fall on Donald Trump's targeted attack

BSE Healthcare Index fell 1.1%, while India's benchmark Sensex Index ... Mumbai: Shares of pharmaceuticals companies on Thursday fell after US ...
Read more: Pharma stocks fall on Donald Trump's targeted attack

Pharma Reviews: Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment

The US is a big export market for many Indian drug companies. Dr Reddy's Laboratories, Sun Pharmaceutical Industries and Lupin were the most hit, ...
Read more: Pharma Stocks Hit After Trump's 'Getting Away With Murder' Comment

Pharma Reviews: Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip

“I don't think these are going to be big issues; if Indian pharma companies are supplying these products to the US markets and if there are no US ...
Read more: Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip

Pharma Reviews: India markets open marginally up; Pharma stocks hit on Donald Trump's presser; Nifty trading ...

Benchmark Indian indices opened marginally higher with most Pharmaceutical stocks taking a major beating after the US President-elect Donald ...
Read more: India markets open marginally up; Pharma stocks hit on Donald Trump's presser; Nifty trading ...

Pharma Reviews: Gujarat govt to sign 250 MoUs related to pharma sector at Vibrant Gujarat Global Summit-2017

These MoUs come at a time when Gujarat has become a favoured pharmaceutical hub accounting for nearly 40 per cent of India's pharma production ...
Read more: Gujarat govt to sign 250 MoUs related to pharma sector at Vibrant Gujarat Global Summit-2017

Pharma Reviews: I don't see Trump's views affecting Indian drug cos: Biocon CMD

Following US president-elect Donald Trump's explosive speech last night where he lambasted the domestic pharma companies for outsourcing work, ...
Read more: I don't see Trump's views affecting Indian drug cos: Biocon CMD

Pharma Reviews: IT, pharma in focus after Trump's tough talk on pricing

US president-elect claimed pharmaceutical companies were “getting away with ... shortly after price approvals, which could impact pharma companies. ... of Obamacare would impact the Indian pharma sector in one way or the other.
Read more: IT, pharma in focus after Trump's tough talk on pricing

Pharma Reviews: Opening bell: Asian markets open mixed; pharma stocks, TCS in focus

US president-elect Donald Trump has attacked the pharmaceutical industry for high drug prices and ... US is the largest market for Indian drug firms.
Read more: Opening bell: Asian markets open mixed; pharma stocks, TCS in focus

Pharma Reviews: Life sciences key to UK-India links

"In Britain, there are 5,500 companies in the life sciences sector generating 60 billion pounds each year. Gujarat's role in the Indian pharma industry is ...
Read more: Life sciences key to UK-India links

Pharma Reviews: Big Trump card could hit Indian IT, pharma! Five takeaways from presser

NEW DELHI: The first presser of US President-elect Donald Trump could put IT and pharma stocks in a tight spot when the domestic market opens for ...
Read more: Big Trump card could hit Indian IT, pharma! Five takeaways from presser

US FDA News: Medrad Intego PET Infusion System Source Administration Sets by Bayer: Recall - Particulates Generated in Vial

The particulate matter could enter into the patient and cause serious adverse health consequences including infection, damage of tissue, and death.
Read more: Medrad Intego PET Infusion System Source Administration Sets by Bayer: Recall - Particulates Generated in Vial

US FDA News: Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication - Important Safety Precautions

Reports of serious adverse events, including patient injury & death, describing medication dosing inaccuracies and other mechanical problems with pumps after an MRI exam.
Read more: Implantable Infusion Pumps in the Magnetic Resonance (MR) Environment: FDA Safety Communication - Important Safety Precautions

Pharma Reviews: Sunset for public sector drug makers

The life story of these companies is intricately linked to the birth and growth of India's pharmaceutical industry and they have played a key role in ...
Read more: Sunset for public sector drug makers

Pharma Reviews: Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%

New Delhi: Sales in the Indian pharmaceutical market grew 7.2 per cent on year to Rs 91.31 billion in December on account of strong growth in sales ...
Read more: Driven by anti-diabetic & cardiac drug sales, Indian pharma grew by 7.2%

Pharma Reviews: LSCPL, Convalgroup to launch Conval Academy for computerized system validation course

If students are trained in CSV upfront, then apart from their own career prospects, Indian pharmaceutical industry will be benefited with their special ...
Read more: LSCPL, Convalgroup to launch Conval Academy for computerized system validation course

Pharma Reviews: SES highlights long receivables period for Indian pharma companies

The report, which compared receivables turnover ratios of 24 pharmaceutical companies for last three fiscal years, showed that Glenmark's ...
Read more: SES highlights long receivables period for Indian pharma companies

Pharma Reviews: ChrysCapital to sell stake in Intas Pharma

Intas is among the top 10 Indian drug firms and the largest privately held pharmaceutical company in India, with annual turnover in excess of $1 billion, ...
Read more: ChrysCapital to sell stake in Intas Pharma

Pharma Reviews: India has the biggest potential for Geistlich Pharma: Paul Note

Ours is a family-based company headquartered in Lausanne, Switzerland. ... Creation of Geistlich Pharma India was needed to serve the dental ...
Read more: India has the biggest potential for Geistlich Pharma: Paul Note

Pharma Reviews: Revised National IPR Policy India- From Industry And Public Development Perspective

This has given a great reprise to the Indian generic pharma industry, otherwise in case patents are granted to International firms like Tykerb which ...
Read more: Revised National IPR Policy India- From Industry And Public Development Perspective

Pharma Reviews: Intas Pharmaceuticals Completes Deal to Acquire Actavis

Intas Pharmaceuticals Completes Deal to Acquire Actavis UK & Ireland Generics Businesses From Teva AHMEDABAD, India, January 10, ...
Read more: Intas Pharmaceuticals Completes Deal to Acquire Actavis

Pharma Reviews: Indian pharma market grew by 7.2% to

Indian pharma market achieved lower growth of 7.2 per cent during the month of December 2016 as compared to 11.9 per cent in the corresponding ...
Read more: Indian pharma market grew by 7.2% to

Monday, January 9, 2017

US FDA News: Implantable Cardiac Devices and Merlin@home Transmitter by St. Jude Medical: FDA Safety Communication - Cybersecurity Vulnerabilities Identified

These vulnerabilities, if exploited, could allow an unauthorized user to remotely access a patient's RF-enabled implanted cardiac device by altering the Merlin@home Transmitter.
Read more: Implantable Cardiac Devices and Merlin@home Transmitter by St. Jude Medical: FDA Safety Communication - Cybersecurity Vulnerabilities Identified

Pharma Jobs: Business Development Manager / BDM / Sales Manager /Dairy farming(Dairy Industry/veterinary)

Company: Deltech Health Care Private Limited
Experience: 5 to 10
location: Chandigarh, Ludhiana
Ref: 19942192
Summary: Hiring Business Development Manager/BDM/Sales Manager/Dairy farming(Dairy Industry/veterinary)with relevant experience of the cattle health sector, with a stress on helping the farmer to control mastitis in ....

Read more: Business Development Manager / BDM / Sales Manager /Dairy farming(Dairy Industry/veterinary)

Pharma Reviews: Indian drug market growth moderates to 7.2% in December

The domestic drug market grew at 7.2 percent in December, compared to 15.5 percent growth in November due to slowdown in uptake of chronic ...
Read more: Indian drug market growth moderates to 7.2% in December

Pharma Reviews: Ajanta Pharma receives US FDA nod for Duloxetine capsules

Ajanta Pharma receives US FDA nod for Duloxetine capsules ... Mumbai headquartered specialty pharmaceutical company Ajanta Pharma in an ... news concerning the Indian pharma industry and other regulatory concerns.
Read more: Ajanta Pharma receives US FDA nod for Duloxetine capsules

Pharma Reviews: Pharma companies want you to pay more for 'risky' bioresorbable stents

Bioresorbable stents were introduced into the Indian market and in Europe by Abbott in 2012. However, it did not receive US FDA approval till March ...
Read more: Pharma companies want you to pay more for 'risky' bioresorbable stents

Sunday, January 8, 2017

Pharma Reviews: Health ministry to mandate upgradation of Schedule M units to WHO-GMP level

Global GMP violations have hurt India's image as an inexpensive and ... Also, Indian pharmaceutical companies have the largest share of DMFs and ...
Read more: Health ministry to mandate upgradation of Schedule M units to WHO-GMP level

Pharma Reviews: Glenmark Pharmaceuticals: Making a mark - Buy

The year 2016 was a docile one for Indian pharma companies. Regulatory tightening by the US drug regulator, coupled with price cuts in India, did not ...
Read more: Glenmark Pharmaceuticals: Making a mark - Buy

Saturday, January 7, 2017

Pharma Reviews: Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn

Aurobindo Pharma will acquire Generis through its wholly-owned ... Indian pharmaceutical companies have been stitching strategic deals in the past ...
Read more: Aurobindo Pharma to buy Portugal's Generis Farmaceutica for $142 mn

Friday, January 6, 2017

Pharma Reviews: How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US

“Innovative brands as opposed to supplying generics to distributors is a significant shift. Indian companies are at a stage of maturity where building a ...
Read more: How top Indian drug makers like Sun Pharma, Glenmark are building a brands business in the US

Pharma Reviews: ACG expanding its footprint across the globe by focusing on quality products

ACG ACPL is one of the largest producers among pharmaceutical grade ... India's leadership and competitive advantage in global pharmaceutical ...
Read more: ACG expanding its footprint across the globe by focusing on quality products

Thursday, January 5, 2017

Pharma Jobs: Urgent Requirements for Managers in health care in Canada

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....

Read more: Urgent Requirements for Managers in health care in Canada

Pharma Jobs: Urgent openings for Physicists and astronomers in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....

Read more: Urgent openings for Physicists and astronomers in Canada.

Pharma Jobs: Urgent opening for Chemists in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....

Read more: Urgent opening for Chemists in Canada.

Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....

Read more: Urgent requirement for Chemical technologists and technicians in canada.

Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada

Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888543
Summary: Chemical technologists and technicians provide technical support and services/may work independently in chemical engineering, chemical and biochemical research and....

Read more: Urgent requirement for Chemical technologists and technicians in canada

Pharma Jobs: Urgent requirement for Biological technologists and technicians in canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Pharm, Other
Experience: 1 to 10
location: Canada
Ref: 19888826
Summary: Biological technologists and technicians provide technical support and services to scientists, engineers and other professionals working in fields.

Read more: Urgent requirement for Biological technologists and technicians in canada.

Pharma Jobs: Urgent openings for Chemical engineers in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.E/B.Tech, M.E/M.Tech/MS
Experience: 1 to 10
location: Canada
Ref: 19888976
Summary: Chemical engineers design, develop chemical processes, equipment, the operation and maintenance of industrial chemical, plastics, pharmaceutical, resource,....

Read more: Urgent openings for Chemical engineers in Canada.

Pharma Jobs: Looking for Inspectors in public, environmental health, occupational health, safety in canada

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.

Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada

Pharma Jobs: Urgent openings for Specialist physicians in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: B.Sc, Other
Experience: 1 to 10
location: Canada
Ref: 19891381
Summary: This unit group includes specialist physicians in clinical medicine, in laboratory medicine and surgery. Specialists in clinical medicine diagnose/treat diseases and....

Read more: Urgent openings for Specialist physicians in Canada.

Pharma Jobs: QC Chemist

Company: Vitasta Consulting Private Limited
Qualification: Other
Experience: 2 to 3
location: Pune
Ref: 19898263
Summary: Job Description To carry outsampling of RM under the guidance To ensure that material testing ,inspection & quality testing of raw materials are done in a timely & accurate manner To insure proper....

Read more: QC Chemist

Pharma Reviews: 'Post demonetisation, money with banks should be used for infra projects'

If the Indian industry has to become globally competitive, I think the interest ... Indian pharma companies are increasingly falling foul of the US FDA.
Read more: 'Post demonetisation, money with banks should be used for infra projects'

Pharma Reviews: Sale of India's First Pharma Company approved by the Union Cabinet

The Union Cabinet chaired by the Prime Minister Narendra Modi has recently approved strategic sale of India's first pharmaceutical company, Bengal ...
Read more: Sale of India's First Pharma Company approved by the Union Cabinet

Pharma Reviews: Why there is a problem with pharma companies sponsoring medical conferences in India

This practice of Indian medical conferences being sponsored by pharmaceutical companies has prompted questions from activists. Jan Swasthya ...
Read more: Why there is a problem with pharma companies sponsoring medical conferences in India

Tuesday, January 3, 2017

Pharma Reviews: Indian companies grab 34% of total US FDA approvals during 2016

Indian pharmaceutical companies have registered strong presence in highly regulated markets like US and Europe with rising investment in research ...
Read more: Indian companies grab 34% of total US FDA approvals during 2016

Pharma Reviews: Outlook 2017: Five trends to watch out for in healthcare space

Drugmaker Laurus Labs also joined a strong list of pharmaceutical ... second-biggest overseas acquisition by an Indian pharmaceutical company ever ...
Read more: Outlook 2017: Five trends to watch out for in healthcare space

Pharma Reviews: Japanese companies make cautious return to Indian pharma market

MUMBAI: After burning their fingers more than once in India with troubled acquisitions, Japanese drug makers are back in this market, this time ...
Read more: Japanese companies make cautious return to Indian pharma market

Pharma Reviews: 350 MSMEs to be set up in phase-1 of Pharma City in Telangana

While talking with KNN, Past President of Indian Pharmaceutical Association, Dr. JAS Giri said that the move by state government will certainly boost ...
Read more: 350 MSMEs to be set up in phase-1 of Pharma City in Telangana

Pharma Reviews: 4th Nigeria Pharma Manufacturers Expo 2017 to be held from Aug 30-Sept 1

4th Nigeria Pharma Manufacturers Expo 2017 (NPME 2017), an international exhibition on pharmaceutical industry is happening for the 4th time ...
Read more: 4th Nigeria Pharma Manufacturers Expo 2017 to be held from Aug 30-Sept 1

Monday, January 2, 2017

Pharma Jobs: Urgent Requirements for Managers in health care in Canada

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate
Experience: 1 to 10
location: Canada
Ref: 19881544
Summary: This unit group includes managers who plan, organize, direct, control and evaluate the delivery of health care services, such as diagnosis and treatment, nursing and therapy,....

Read more: Urgent Requirements for Managers in health care in Canada

Pharma Jobs: Urgent openings for Physicists and astronomers in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886030
Summary: Physicists conduct theoretical applied research to extend knowledge of natural phenomena to develop new processes and devices in fields like electronics, communications, power....

Read more: Urgent openings for Physicists and astronomers in Canada.

Pharma Jobs: Urgent opening for Chemists in Canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886133
Summary: Chemists conduct research and analysis in support of industrial operations, product and process development, quality control, environmental control, medical diagnosis and treatment,....

Read more: Urgent opening for Chemists in Canada.

Pharma Jobs: Urgent requirement for Chemical technologists and technicians in canada.

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Other
Experience: 1 to 10
location: Canada
Ref: 19886557
Summary: Chemical technologists and technicians provide technical support and services /may work independently in chemical engineering, chemical and biochemical research and analysis, industrial ....

Read more: Urgent requirement for Chemical technologists and technicians in canada.

Pharma Jobs: Looking for Inspectors in public, environmental health, occupational health, safety in canada

Company: Kanvisa Overseas Consultants Private Limited
Qualification: Any graduate, Diploma, Other
Experience: 1 to 10
location: Canada
Ref: 19890980
Summary: Inspectors in this unit group evaluate and monitor health and safety hazards and develop strategies to control risks in the workplace.

Read more: Looking for Inspectors in public, environmental health, occupational health, safety in canada

Pharma Jobs: Eexecutive - Analytical & Formulation -Injactable

Company: ScaleneWorks People Solutions LLP
Qualification: B.E/B.Tech
Experience: 2 to 6
location: Pune
Ref: 19908062
Summary: · Responsible for Planning of daily work by maintaining GLP, cGMP’s as per company procedures · Responsible for interpretation of analytical data and communicating the same to concern groups ....

Read more: Eexecutive - Analytical & Formulation -Injactable

Pharma Jobs: Medical Coding For M.Pharmacy / B.Pharmacy Graduates

Company: ScaleneWorks People Solutions LLP
Experience: 0 to 5
location: Other India
Ref: 19908112
Summary: Designation-Medical Coder Trainee Eligibility… Nursing Pharmacy Biotechnology Microbiology Bio Medical Bio Chemistry Bio Informatics Biology Chemistry Botany Zoology Advanced Zoology PlantBiology Anatomy ....

Read more: Medical Coding For M.Pharmacy / B.Pharmacy Graduates

Pharma Jobs: clinical Research Associate

Company: ScaleneWorks People Solutions LLP
Experience: 2 to 3
location: Ahmedabad
Ref: 19910603
Summary:

Read more: clinical Research Associate

Pharma Jobs: Scientific Manager Protein Formulation

Company: ScaleneWorks People Solutions LLP
Experience: 2 to 6
location: Bengaluru / Bangalore
Ref: 19910845
Summary: Biocon is an integrated biotechnology enterprise focused on the development of biopharmaceuticals With successful initiatives in drug discovery and development bioprocessing manufacturing and global marketing....

Read more: Scientific Manager Protein Formulation

Pharma Jobs: Regulatory Affairs Manager

Company: ScaleneWorks People Solutions LLP
Experience: 0 to 1
location: Bhopal
Ref: 19911952
Summary: Supervising central and non-central European licensing procedures (new applicationsor variationsor renewals. Establishment and maintenance of contacts between MSD AH and EU regulatory authorities. Advising on regulatory....

Read more: Regulatory Affairs Manager

Pharma Jobs: Research Associate - Fresher - Andheri, Mumbai

Company: ScaleneWorks People Solutions LLP
Experience: 0 to 1
location: Mumbai, Navi Mumbai
Ref: 19912473
Summary: Loc : Andheri, Mumbai Exp - 0 t0 1 year Qualification : Graduate (any stream; preferably IT/Computer Science) with an IT background Gender : Male / Female Job Description : * Understanding and defining the....

Read more: Research Associate - Fresher - Andheri, Mumbai

Pharma Jobs: Research Associate - Education Startup

Company: ScaleneWorks People Solutions LLP
Experience: 2 to 4
location: Bengaluru / Bangalore
Ref: 19912951
Summary: Current Clientele : Premier schools of the country including: The Doon School, Lawrence School Sanawar, Sishya School Chennai, NPS Bangalore etc. They service 70 schools in 15 states. The Research Associate is....

Read more: Research Associate - Education Startup

Pharma Jobs: Urgent opening for M.Sc / M. A Psychology Patiala District

Company: ScaleneWorks People Solutions LLP
Qualification: M.Sc
Experience: 0 to 1
location: Patiala
Ref: 19913448
Summary: Experience: Fresher Salary: 10k to 15k PM Location : Patiala (Punjab) Company : Hospital No. of opening : 4 Person should have done M.Sc / M.A psychology or any candidate with Clinical Psychology.....

Read more: Urgent opening for M.Sc / M. A Psychology Patiala District

Pharma Reviews: Outlook for pharma, education and microfinance in 2017

What can the Indian pharma companies hope to look forward to in the new year? After all, market headwinds in the form of drug pricing pressures ...
Read more: Outlook for pharma, education and microfinance in 2017

Pharma Reviews: Recipharm receives FIPB approval to acquire Kemwell's Indian operation

The second acquisition, regarding Kemwell's pharmaceutical operations in India, was conditional on governmental approvals, and was expected to ...
Read more: Recipharm receives FIPB approval to acquire Kemwell's Indian operation

Pharma Reviews: New Year, new requirements- Cos stare at high compliance costs with new laws

Indian pharma companies are taking regulatory risks emanating from US FDA, US Foreign Corrupt Practices Act and Indian government's Uniform ...
Read more: New Year, new requirements- Cos stare at high compliance costs with new laws

Sunday, January 1, 2017

Pharma Reviews: Pharma & healthcare sectors see R&D, manufacture & predictive analytics as growth drivers in 2017

Indian pharma companies will prove its mettle in R&D and manufacture in 2017. The sector's capability holds immense potential in contract research ...
Read more: Pharma & healthcare sectors see R&D, manufacture & predictive analytics as growth drivers in 2017